Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
33%
Ph not_applicable
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_1

Safety Study of 3D Printing Personalized Biodegradable Implant for Breast Reconstruction

NCT03348293
completed

Left Atrial Appendage Occlusion Guided by 3D Printing

NCT03330210
unknownnot_applicable

Applicability of 3D Printing and 3D Digital Image Reconstruction in the Planning of Complex Liver Surgery (LIV3DPRINT).

NCT03416387

Clinical Trials (3)

Showing 3 of 3 trials
NCT03348293Phase 1

Safety Study of 3D Printing Personalized Biodegradable Implant for Breast Reconstruction

Completed
NCT03330210

Left Atrial Appendage Occlusion Guided by 3D Printing

Completed
NCT03416387Not Applicable

Applicability of 3D Printing and 3D Digital Image Reconstruction in the Planning of Complex Liver Surgery (LIV3DPRINT).

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3